
Investor Relations Captor Therapeutics ®
Notification of a reduction in the number of shares held in the Company
Current report no. 2/2025
Drafting date: 21 January 2025
Subject: Notification of a reduction in the number of shares held in the Company
Legal basis: Article 70(1) of the Act on Public Offering - acquisition or disposal of a significant block of shares
The Management Board of Captor Therapeutics S.A., with its registered office in Wrocław (the “Company”), announces that it has received a notification from Paweł Holstinghausen-Holsten, prepared pursuant to Article 69 of the Act of 29 July 2005 on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organised Trading, and Public Companies, regarding the decrease of the participation in the total number of votes at the Company's General Meeting by Paweł Holstinghausen-Holsten, individually, and by his subsidiary, the ‘Holstinghausen-Holsten Family Foundation’.
The decrease of the share in the total number of votes is related to the registration of the increase of the Company's share capital carried out through the issue of 822,467 Series T ordinary bearer shares, of which the Company informed in current report No. 47/2024 of 30 December 2024.
The content of the notification is attached to this report.